clinical trial · NCT05645887
Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.
Albimmune SL·phase2·withdrawn
Septic ShockHuman albuminSaline solution
brief summary
The goal of this phase 2, multicenter, randomized, controlled study is to evaluate the effect of albumin treatment on B cell and other immune cell gene exptression in adults with septic shock.
started
Feb 1, 2024
primary completion
May 23, 2024
completion
May 23, 2024
last updated
Jul 31, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol